Ausdal Financial Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,479	Closed	-$291K	–	469
2022 Q4	$291K	Sell	6,479 -140	-2%	-$6.34K	0.04%	345
2022 Q3	$317K	Hold	6,619	–	–	0.05%	319
2022 Q2	$392K	Buy	6,619 +500	+8%	+$41K	0.06%	300
2022 Q1	$712K	Buy	6,119 +610	+11%	+$71.2K	0.1%	219
2021 Q4	$829K	Sell	5,509 -2,001	-27%	-$270K	0.11%	205
2021 Q3	$897K	Sell	7,510 -1,000	-12%	-$110K	0.13%	191
2021 Q2	$829K	Buy	8,510 +774	+10%	+$69K	0.13%	193
2021 Q1	$683K	Sell	7,736 -2,343	-23%	-$218K	0.12%	204
2020 Q4	$513K	Buy	10,079 +5,077	+101%	+$523K	0.1%	218
2020 Q3	$568K	Sell	5,002 -500	-9%	-$52.5K	0.14%	171
2020 Q2	$544K	Sell	5,502 -3,100	-36%	-$247K	0.18%	132
2020 Q1	$626K	Buy	8,602 +90	+1%	+$6.31K	0.22%	118
2019 Q4	$655K	Sell	8,512 -357	-4%	-$22K	0.19%	134
2019 Q3	$523K	Buy	8,869 +357	+4%	+$22.8K	0.19%	144
2019 Q2	$548K	Buy	8,512 +1,562	+22%	+$101K	0.21%	130
2019 Q1	$441K	Sell	6,950 -3,075	-31%	-$162K	0.18%	148
2018 Q4	$381K	Sell	10,025 -7,750	-44%	-$274K	0.19%	137
2018 Q3	$761K	Sell	17,775 -4,725	-21%	-$165K	0.21%	137
2018 Q2	$495K	Sell	22,500 -12,150	-35%	-$149K	0.15%	195
2018 Q1	$172K	Buy	34,650 +5,000	+17%	+$16.1K	0.06%	336
2017 Q4	$70K	Buy	+29,650	New	+$93.1K	0.03%	347